FAP and ductal breast carcinoma in situ: In 49 DCIS recurrence cases, the percentages of grade 3, 2, and 1 of stromal FAP-a immunostaining were 65.31% (32/49), 18.37% (9/49), and 16.33% (8/49), respectively.